News

Using the company’s novel and proprietary monomeric Fc fusion technology, clotting factor rFIXFc provides long-lasting protection from bleeding and reduces the treatment burden associated with hemophilia B. The

The small molecule therapeutic, which has dual mode of action including anti-catabolic and pro-anabolic activity, is indicated for the treatment of cancer cachexia, a wasting syndrome characterized by

The collaboration was formed to discover novel small molecules for an undisclosed target using Vernalis’ fragment and structure-based drug discovery technology. Vernalis said the final payment is in

Oral retinoid compound tamibarotene, which was designed to be superior to all trans-retinoic acid (ATRA) by binding to the molecular target more selectively, proved to be 10 times

The firm is planning to invest the fund in its Phase I clinical development of SB 9200, a novel, orally available treatment for Hepatitis C virus (HCV) infection

The firm is planning to use the fund to commercialize its portfolio of dysphagia treatment products and to add new products and services. Venture Management president Terry Kelly

The firm’s new tunnels are equipped with Intense Pulsed UV flash lamps, which contain UV transparent conveyer and capable of sterilizing the entire product surfaces with the reduction

Under the agreement, RxMedic will immediately become a distributor of Rx Systems’ Eyecon Countertop Counter, along with their existing line of advanced pharmacy automation systems. The Eyecon is

Under $130,000 grant, TriLink plans to investigate methods to reduce formation of adapter dimers during RNA sample preparation, which will remove the need for gel purification prior to